Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study

被引:74
|
作者
Jakimovski, D. [1 ]
Gandhi, S. [1 ]
Paunkoski, I. [1 ]
Bergsland, N. [1 ]
Hagemeier, J. [1 ]
Ramasamy, D. P. [1 ]
Hojnacki, D. [2 ]
Kolb, C. [2 ]
Benedict, R. H. B. [2 ]
Weinstock-Guttman, B. [2 ]
Zivadinov, R. [1 ,3 ]
机构
[1] SUNY Buffalo, Dept Neurol, Jacobs Sch Med & Biomed Sci, Buffalo Neuroimaging Anal Ctr, Buffalo, NY USA
[2] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Jacobs Comprehens MS Treatment & Res Ctr, Buffalo, NY USA
[3] SUNY Buffalo, Clin Translat Sci Inst, Ctr Biomed Imaging, Buffalo, NY USA
基金
美国国家卫生研究院;
关键词
brain atrophy; heart disease; hypertension; lateral ventricular volume; MRI; multiple sclerosis; LIPID PROFILE; SMOKING; COMORBIDITY; PROGRESSION; DISABILITY; INCREASES; VOLUMES; DELAYS; RISK;
D O I
10.1111/ene.13769
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Cardiovascular diseases (CVDs) are more frequent in multiple sclerosis (MS) patients when compared to controls. In particular, CVDs are linked with higher accumulation of lesions and advanced brain atrophy. Objective To investigate whether CVDs contribute to accelerated lesion accumulation and brain atrophy over 5 years in patients with MS. Methods 194 MS patients and 43 controls without neurologic disease were followed for 5 years. Full physical, neurological evaluation, and structured questionnaire investigating CVD and risk factors (hypertension, hyperlipidemia, heart disease, smoking, diabetes, obesity/overweight) were collected using interview-based questionnaire and further cross-reference with electronic medical records. Lesion and brain atrophy outcomes were assessed with 3T MRI. ANCOVA adjusted for age, gender, and disease duration were used accordingly. False discovery rate correction was performed using Benjamini-Hochberg correction. Results Patients with diagnosis of heart disease showed higher white matter and whole brain volume loss compared to those without (-4.2% vs. -0.7%, P = 0.01 and -3.4% vs. -1.6%, P = 0.01, respectively). The percentage lateral ventricle volume change in MS patients with hypertension was higher compared to non-hypertensive patients (24.5% vs. 14.1%, P = 0.05). Hyperlipidemia, smoking, and obesity/overweight were not associated with progression of MRI-derived outcomes. CVDs did not contribute to larger lesion volume accrual over the 5-year period. The presence of CVDs was not associated with MRI-derived changes in the controls. Conclusions Hypertension and heart disease contribute to advanced brain atrophy in MS patients. CVDs did not contribute to additional lesion accrual. CVD comorbidities in MS patients may contribute to neurodegenerative tissue injury that can be detected with brain MRI.
引用
收藏
页码:87 / +
页数:8
相关论文
共 50 条
  • [1] Brain Atrophy in Natalizumab-treated Patients with Multiple Sclerosis: A 5-year Retrospective Study
    Eisele, Philipp
    Szabo, Kristina
    Ebert, Anne
    Platten, Michael
    Gass, Achim
    JOURNAL OF NEUROIMAGING, 2019, 29 (02) : 190 - 192
  • [2] Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
    Hanninen, Katariina
    Viitala, Matias
    Paavilainen, Teemu
    Karhu, Jari O.
    Rinne, Juha
    Koikkalainen, Juha
    Lotjonen, Jyrki
    Soilu-Hanninen, Merja
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [3] Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis A 5-year longitudinal study
    Horakova, Dana
    Dwyer, Michael G.
    Havrdova, Eva
    Cox, Jennifer L.
    Dolezal, Ondrej
    Bergsland, Niels
    Rimes, Brett
    Seidl, Zdenek
    Vaneckova, Manuela
    Zivadinov, Robert
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 282 (1-2) : 112 - 119
  • [4] Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: Results of a 5-year follow-up study
    Dolezal, Ondrej
    Gabelic, Tereza
    Horakova, Dana
    Bergsland, Niels
    Dwyer, Michael G.
    Seidl, Zdenek
    Krasensky, Jan
    Ramasamy, Deepa P.
    Vaneckova, Manuela
    Havrdova, Eva
    Zivadinov, Robert
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S42 - S48
  • [5] Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis
    Hanninen, Katariina
    Viitala, Matias
    Paavilainen, Teemu
    Karhu, Jari O.
    Rinne, Juha
    Koikkalainen, Juha
    Lotjonen, Jyrki
    Soilu-Hanninen, Merja
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [6] Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study
    Jakimovski, Dejan
    Weinstock-Guttman, Bianca
    Gandhi, Sirin
    Guan, Yi
    Hagemeier, Jesper
    Ramasamy, Deepa P.
    Fuchs, Tom A.
    Browne, Richard W.
    Bergsland, Niels
    Dwyer, Michael G.
    Ramanathan, Murali
    Zivadinov, Robert
    JOURNAL OF NEUROLOGY, 2019, 266 (04) : 866 - 875
  • [7] Progression of Regional Atrophy in the Left Hemisphere Contributes to Clinical and Cognitive Deterioration in Multiple Sclerosis: A 5-Year Study
    Preziosa, Paolo
    Pagani, Elisabetta
    Mesaros, Sarlota
    Riccitelli, Gianna C.
    Dackovic, Jelena
    Drulovic, Jelena
    Filippi, Massimo
    Rocca, Maria A.
    HUMAN BRAIN MAPPING, 2017, 38 (11) : 5648 - 5665
  • [8] Functional Disability and Brain MRI Volumetry Results among Multiple Sclerosis Patients during 5-Year Follow-Up
    Strautmane, Sintija
    Balodis, Arturs
    Teivane, Agnete
    Grabovska, Dagnija
    Naudins, Edgars
    Urbanovics, Daniels
    Fisermans, Edgars
    Mednieks, Janis
    Flintere-Flinte, Alina
    Priede, Zanda
    Millers, Andrejs
    Zolovs, Maksims
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [9] Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study
    Granberg, Tobias
    Martola, Juha
    Bergendal, Gosta
    Shams, Sara
    Damangir, Soheil
    Aspelin, Peter
    Fredrikson, Sten
    Kristoffersen-Wiberg, Maria
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (09) : 1151 - 1158
  • [10] Apolipoprotein E ε4-Positive Multiple Sclerosis Patients Develop More Gray-Matter and Whole-Brain Atrophy: a 15-Year Disease History Model Based on a 4-Year Longitudinal Study
    Horakova, D.
    Kyr, M.
    Havrdova, E.
    Dolezal, O.
    Lelkova, P.
    Pospisilova, L.
    Bergsland, N.
    Dwyer, M. G.
    Cox, J. L.
    Hussein, S.
    Seidl, Z.
    Vaneckova, M.
    Krasensky, J.
    Zivadinov, R.
    FOLIA BIOLOGICA, 2010, 56 (06) : 242 - 251